Resources

How much time do you spend with a patient newly diagnosed with type 2 diabetes,, even though you refer them for diabetes education? Follow the link to share your response.

We know treating and living with diabetes and excess weight or obesity takes a village, a multidisciplinary village, not only related to the patient and health care providers but truly the whole village or world. It also helps to remember the seasons and reasons why we do the things we do. We sometimes forget about how changes in weather, our personal cultures, living environment, even friends and loved ones who seemingly mean well can “sabotage" the greatest intentions.

 In part 2 of this 2-part Homerun Slides series, Finnish vs ADA diabetes risk scores. To download the complete set in PowerPoint format, just use this link: Prediabetes Part 2. Catch up on past Homerun Slides for the Hypertension Update: Prediabetes Part 1.

The dominance of beta-cell functional impairment: As discussed earlier, the available evidence indicates that an average 30% loss of beta-cells is present in the islets of patients with T2DM. However, based on a series of considerations it is unlikely that this beta-cell deficit alone is the cause of most cases of diabetes. First, in vivo assessment of beta-cell function consistently shows a greater than 50% reduction in patients with overt T2DM, a difference that is amplified when using intravenous glucose.

Administration releases “American Patient First” blueprint to lower drug prices, reduce out-of-pocket costs.

Glyburide versus subcutaneous insulin did not result in a greater frequency of perinatal complications.

Weight loss between young adulthood and midlife found to create statistically significant reductions in risk for diabetes.

Very small proportion of U.S. adults engage in risk reduction behaviors like proper diet and exercise for type 2 diabetes.

Use of metformin may decrease chances of developing gastric cancer in patients with T2D.

Guest Post by David Kliff, Editor, Diabetic Investor

The so-called “high” cost of insulin continues to get lots of attention. But as I’ve noted before, little perspective has been given to this debate and far too many facts are missing. Yes, I know facts are pesky things, but they are facts nonetheless. Allow me for a moment to provide some examples.